Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
medicabilis cbd oil
- Development stage
- Phase 4
- Lead developer
- Bod Australia
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Oral, Sublingual
01
Overview
MediCabilis CBD oil is a pharmaceutical-grade full-spectrum cannabis oil extract derived from a unique cultivar of Cannabis sativa L. (LINNEA 315CSE). The formulation is standardized to deliver cannabidiol (CBD and CBDA) at 50 mg/mL with low levels of delta-9-tetrahydrocannabinol (THC), not exceeding 2 mg/mL. It also contains minor cannabinoids such as cannabigerol (CBG), cannabichromene (CBC), and cannabidivarin (CBDV) in smaller amounts. The carrier is medium chain triglyceride (MCT) oil sourced from coconut. This product is manufactured under GMP conditions and has been used in clinical trials for chronic conditions such as Long COVID. Its mechanism of action primarily involves modulation of the endocannabinoid system through cannabinoid receptors, with non-intoxicating effects due to its high CBD and low THC content[1][2][7][9].
- Brand names
- MediCabilisMediCabilis 50MediCabilis50MediCabilis-50MediCabilis CBD50MediCabilis 5% CBD Oil
- Other names
- MediCabilis Cannabis sativa 50Medicabilis CBD oil
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on medicabilis cbd oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on medicabilis cbd oil.